Author

Hengxing Lu

First Affiliated Hospital Zhejiang University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Hailing Zhang· 2 shared Jin ZhangiD· 2 shared Shaolong ZhangiD· 2 shared Anhua Lei· 1 shared Na Kong· 1 shared Natasha Karyn Lienanto· 1 shared Qixin Wu· 1 shared Wu Qixing· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Hailing Zhang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vivo colonic epithelial cell editing attenuates intestinal inflammation in mice

Hailing Zhang, Hengxing Lu, Shaolong Zhang, Xukai Hu, Wu Qixing, Ziqin Yu, Natasha Karyn Lienanto, Jin Zhang

The paper shows that editing colonic epithelial cells in vivo to enhance efferocytosis reduces intestinal inflammation in mice.

Inflammation Research · May 19, 2026Peer-reviewedBioengineering

In vivo engineered quadrivalent CAR-macrophages break tumor barrier,remodel TME and overcome tumor heterogeneity through antigen spreading

Shaolong Zhang, Hengxing Lu, Hailing Zhang, Xizhong Ding, Qixin Wu, Anhua Lei, Na Kong, Jin Zhang

This study develops in vivo engineered quadrivalent CAR-macrophages that break tumor barriers, remodel the TME, and overcome tumor heterogeneity through antigen spreading, achieving complete tumor regression.

bioRxiv · Nov 6, 2024 · PreprintBioengineering